Glucagon-like petide-1 (GLP-1) is a peptide that is mainly produced by the intestinal cells and is known to improve cardiovascular health [137], improve endothelial function in obesity [138], and stimulate fatty acid oxidation and insulin signalling pathways, thus enhancing the antioxidant capacity [139]. The gene discussed is INS; the disease is obesity disorder.